Drugs and peripheral vascular disease.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000139:chemically induced* / Q000188:drug therapy; D001971:Bromocriptine / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D001971:Bromocriptine; D006493:Heparin